Skip to contentA
Aspira Women's Health Inc.
A
AWHLAspira Women's Health Inc. Released Mar 1, 2013, after the close
10-K filed Mar 1, 2013, 60 days after period end · 0001193125-13-087647
Q4 2012 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.14M$1.14Mderived+31.6% vs Q4 2011 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
+258.0% vs Q3 2012
Net Income-$1.38M-$1.38MderivedN/M vs Q4 2011N/M vs Q3 2012 EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,110,000+31.5% Operating Incomederived-$1,281,000N/M Operating Cash Flowderived-$2,428,000N/M Free Cash Flowderived-$2,428,000N/M Margins · derivedGross margin97.2%−0.0 pt vs Q4 2011
Operating margin-112.2%+241.5 pt vs Q4 2011
Net margin-120.4%+240.8 pt vs Q4 2011
ended Dec 31, 2012 · filed Mar 1, 2013 · 60 d after period end